Biotechnology Assets Statistics

Total Valuation

BME:BST has a market cap or net worth of EUR 21.05 million. The enterprise value is 22.87 million.

Market Cap	21.05M
Enterprise Value	22.87M

Important Dates

The last earnings date was Friday, April 4, 2025.

Earnings Date	Apr 4, 2025
Ex-Dividend Date	n/a

Share Statistics

BME:BST has 67.67 million shares outstanding. The number of shares has increased by 14.28% in one year.

Current Share Class	67.67M
Shares Outstanding	67.67M
Shares Change (YoY)	+14.28%
Shares Change (QoQ)	+7.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.10
PB Ratio	3.18
P/TBV Ratio	4.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.84
EV / Sales	7.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-260.99

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 0.32.

Current Ratio	0.81
Quick Ratio	0.81
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-23.81
Interest Coverage	-12.62

Financial Efficiency

Return on equity (ROE) is -44.40% and return on invested capital (ROIC) is -14.77%.

Return on Equity (ROE)	-44.40%
Return on Assets (ROA)	-9.11%
Return on Invested Capital (ROIC)	-14.77%
Return on Capital Employed (ROCE)	-22.36%
Revenue Per Employee	87,210
Profits Per Employee	-85,803
Employee Count	34
Asset Turnover	0.19
Inventory Turnover	n/a

Taxes

Income Tax	-139,119
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.17% in the last 52 weeks. The beta is 1.56, so BME:BST's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	-14.17%
50-Day Moving Average	0.31
200-Day Moving Average	0.31
Relative Strength Index (RSI)	46.14
Average Volume (20 Days)	242,819

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:BST had revenue of EUR 2.97 million and -2.92 million in losses. Loss per share was -0.04.

Revenue	2.97M
Gross Profit	2.62M
Operating Income	-2.29M
Pretax Income	-3.06M
Net Income	-2.92M
EBITDA	-1.29M
EBIT	-2.29M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 261,856 in cash and 2.09 million in debt, giving a net cash position of -1.82 million or -0.03 per share.

Cash & Cash Equivalents	261,856
Total Debt	2.09M
Net Cash	-1.82M
Net Cash Per Share	-0.03
Equity (Book Value)	6.61M
Book Value Per Share	0.10
Working Capital	-851,300

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -73,854 and capital expenditures -13,765, giving a free cash flow of -87,619.

Operating Cash Flow	-73,854
Capital Expenditures	-13,765
Free Cash Flow	-87,619
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 88.19%, with operating and profit margins of -77.17% and -98.39%.

Gross Margin	88.19%
Operating Margin	-77.17%
Pretax Margin	-103.08%
Profit Margin	-98.39%
EBITDA Margin	-43.60%
EBIT Margin	-77.17%
FCF Margin	n/a

Dividends & Yields

BME:BST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.28%
Shareholder Yield	n/a
Earnings Yield	-13.86%
FCF Yield	-0.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:BST has an Altman Z-Score of -8.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.07
Piotroski F-Score	2